News & Highlights

Skyrocketing drug prices leave cures out of reach for some patients

Jun 16, 2015

Sophisticated drugs are opening the door, scientists say, to an era of "precision medicine." They're also ushering in an age of astronomical prices. Read More

ICYMI: New poll shows 75% of Americans find Rx prices are just too high.

May 21, 2015

May 21, 2015 Morning Consult: “New Cures, Old Problems: Poll Shows Drug Read More

ICYMI: “Prescription drug prices climb into the stratosphere”

May 20, 2015

May 20, 2015 “Prescription drug prices climb into the stratosphere” Read More

ICYMI: In anticipation of today’s Cures markup, E&C releases an updated draft while Pew launches a new Rx initiative

May 14, 2015

May 14, 2015 The House Energy and Commerce Committee released an updated Read More

ICYMI: FDA Advisory Panel Approves New Cystic-Fibrosis Drug while Americans Continue to Pay the Price of High Cost Drugs

May 13, 2015

May 13, 2015 The New York Times: “Cystic Fibrosis Drug Wins Approval of Read More

ICYMI: “As E&C Prepares Cures Bill Markup, Negative Press On Drug Prices On The Increase”

May 12, 2015

May 12, 2015 InsideHealthPolicy.com Health Reform Insider: “As E&C Read More

ICYMI: Vertex’s Cystic-Fibrosis Drug Could Come at a Cost

May 11, 2015

May 11, 2015 The Wall Street Journal: “Vertex’s Cystic-Fibrosis Read More

Weekly Update – How much is too much?

May 8, 2015

Weekly Update – 5/8/2015 We learned this week that worldwide spending on Read More

ICYMI: Should the Specialty Drug Cost Debate Take a Breath? Data Proves Otherwise.

May 7, 2015

ICYMI: May 7, 2015 PharmaExec.com: “Take a Breath” on the Specialty Drug Read More

ICYMI: Washington’s Role in High Drug Costs — Marketing Exclusivity and “Shadow Pricing”

May 6, 2015

ICYMI: May 6, 2015 National Journal: Washington’s Interest in Precision Read More

ICYMI – Where’s Robert Stack When You Need Him?

May 5, 2015

ICYMI May 5, 2015  The New York Times: Runaway Drug Prices How companies set Read More